Multimodal DNA Nanostructure Barcodes for Single-Cell Protein Profiling and Tumor Subtyping.
Molecular classification of diseases that accurately reflects clinical behavior is fundamental to the realization of precision medicine.
APA
Cui M, Hu C, et al. (2026). Multimodal DNA Nanostructure Barcodes for Single-Cell Protein Profiling and Tumor Subtyping.. ACS nano, 20(7), 5904-5917. https://doi.org/10.1021/acsnano.5c18968
MLA
Cui M, et al.. "Multimodal DNA Nanostructure Barcodes for Single-Cell Protein Profiling and Tumor Subtyping.." ACS nano, vol. 20, no. 7, 2026, pp. 5904-5917.
PMID
41674080
Abstract
Molecular classification of diseases that accurately reflects clinical behavior is fundamental to the realization of precision medicine. Single-cell protein analysis combined with coding technology offers a promising approach for constructing robust molecular classifiers. However, the low abundance of disease-related cells and the technical challenges in parallel profiling of multiple proteins remain major obstacles. Herein, we present a DNA nanostructure-based multicomponent coding strategy that enables multiprotein analysis at the single-cell level by precisely controlling the stoichiometry, orientation, and modularity of the magnetized tags and multicolor fluorescent tags. Compared with conventional linear DNA barcoding methods, our approach allows for the simultaneous magnetic separation of heterogeneous cell populations and multicolor fluorescence-based phenotypic encoding. By integrating single-cell trapping techniques, we demonstrate the accurate molecular subtyping of breast cancer based on fluorescence-encoded phenotypic features. This strategy expands the scope of applications in cell sorting, proteomic profiling, and genomic analysis, thus advancing the frontiers of precision medicine.
MeSH Terms
Humans; Single-Cell Analysis; Nanostructures; DNA; Breast Neoplasms; Proteomics; Female; DNA Barcoding, Taxonomic; Cell Line, Tumor
같은 제1저자의 인용 많은 논문 (5)
- Spatial transcriptomics defines the molecular progression, invasion and immune landscape of IPMN and IPMN-derived pancreatic cancer.
- Medicinal Chemistry Strategies for the Development of CD73 Inhibitors in Cancer Immunotherapy.
- Therapeutic advances in HR+/HER2- advanced breast cancer after failure of CDK4/6 inhibitor therapy.
- Abscopal effect induced by conventional fractionated radiotherapy following anti-PD-1 immunotherapy in pulmonary metastatic thymic squamous cell carcinoma: a case report and literature review.
- L-type calcium channel-mediated lipid metabolic reprogramming in gastric adenocarcinoma progression.